ACI’s 2nd Annual Over-the-Counter Drugs Forum & Inaugural Paragraph IV Disputes Master Symposium

August 4, 2013

The American Conference Institute (“ACI”) will be holding two events in the coming months that are of particular interest to FDA Law Blog readers. . . . and, importantly, for which our readers can get a discount.

The first event is ACI’s Legal, Regulatory, and Compliance Forum on Over-the-Counter Drug, which will take place on October 29-30, 2013 at the Carlton Hotel in New York City.  This is the only legal and regulatory gathering of this nature that we know of that is specifically designed for the OTC drug industry.  The Honorable Edward R. Korman, U.S.D.J. will be presenting on the PLAB B decision.  Judge Korman will join a distinguished faculty of over two dozen leading legal and regulatory OTC drug experts, including Hyman, Phelps & McNamara, P.C.’s Paul M. Hyman, who will be speaking on the OTC drug monograph system.  Other important topics that will be covered include the NSURE initiative, advertising and promotion, labeling, trademarks, trade names, and umbrella branding.  To obtain a copy of the conference brochure and to register for the event, please visit ACI's website – here.

The second event is ACI’s first ever Paragraph IV Disputes Master Symposium, which will take place on October 3-4, 2013 at the Millennium Knickerbocker Hotel in Chicago, Illinois.  This event is designed as a brand-name and generic drug think tank where the leading legal minds in this area meet to exchange information and insights.  Critical sessions will address all facets of Paragraph IV litigation from pre-litigation concerns to the commencement of suit through final adjudication, and the event speakers will delve deeply into each of these elements.  In addition, the symposium will include a panel of several esteemed Federal Jurists from the Districts of Northern Illinois, Eastern Texas, and New Jersey.  Hyman, Phelps & McNamara, P.C.’s Kurt R. Karst will be speaking on recent brand-side and generic-side challenges to marketing exclusivity.  To obtain a copy of the conference brochure and to register for the event, please visit ACI's website – here.

FDA Law Blog is a conference media partner for both events.  As such, we can offer our readers a special $200 discount off the current price tier for each event.  The discount code is: FLB 200.  We look forward to seeing you at both conferences.